tiprankstipranks
Trending News
More News >
Celadon Pharmaceuticals PLC (GB:CEL)
:CEL
UK Market
Advertisement

Celadon Pharmaceuticals PLC (CEL) Income Statement

Compare
15 Followers

Celadon Pharmaceuticals PLC Income Statement

Last quarter (Q2 2024), Celadon Pharmaceuticals PLC's total revenue was £31.50K, an increase of 293.75% from the same quarter last year. In Q2, Celadon Pharmaceuticals PLC's net income was £-1.20M. See Celadon Pharmaceuticals PLC’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
£ 75.00K£ 24.00K£ 2.00K£ 0.00£ 0.00
Gross Profit
£ 1.00K£ -66.00K£ -10.00K£ 0.00£ 0.00
Operating Expenses
£ 5.76M£ 12.85M£ 2.70M£ 720.65K£ 47.45K
Depreciation and Amortization
£ 534.00K£ 466.00K£ 319.00K£ 60.40K£ 47.45K
EBITDA
£ -6.39M£ -13.61M£ -2.39M£ -660.25K£ -191.32K
Operating Income
£ -5.93M£ -5.38M£ -2.71M£ -720.65K£ -47.45K
Other Income/Expenses
£ -1.59M£ -12.74M£ -2.08M£ -339.15K£ -143.87K
Pretax Income
£ -7.52M£ -18.12M£ -4.80M£ -1.06M£ -151.70K
Net Income
£ -7.14M£ -17.41M£ -4.78M£ -1.40M£ -151.70K
Per Share Metrics
Basic EPS
£ -0.12£ -0.30£ -0.10£ -0.23£ -0.03
Diluted EPS
£ -0.12£ -0.30£ -0.10£ -0.23£ -0.03
Weighted Average Shares Outstanding
61.89M 57.30M 48.33M 6.13M 5.31M
Weighted Average Shares Outstanding (Diluted)
61.89M 57.30M 48.44M 6.13M 5.31M
Currency in GBP

Celadon Pharmaceuticals PLC Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis